 Can-Fite BioPharma CANF stock is rocketing higher on Monday thanks to new data from a Phase II clinical trial for liver cancer. The post CANF Stock Alert: The Liver Cancer News Catapulting Can-Fite BioPharma Shares Higher Today appeared first on InvestorPlace. 